Could a common diabetes drug protect aging brains in MS?
NCT ID NCT06463743
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 33 times
Summary
This study tests whether metformin, a diabetes drug, is safe and can protect the brain in people aged 55–75 with multiple sclerosis (MS). Participants will take metformin or a placebo for 9 months, either alone or with their usual MS treatment. The goal is to see if metformin reduces nerve damage and disability progression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UBMD Neurolgy
RECRUITINGBuffalo, New York, 14203, United States
Conditions
Explore the condition pages connected to this study.